In this regard, it has recently been demonstrated that the alteration of some biomarkers is closely related to gynecological cancer and several investigations have reported a significant variation of HE4 levels in SARS-CoV-2-infected patients [11,13]. The gene discussed is WFDC2; the disease is female reproductive organ cancer.